To establish whether pressure-volume areas (PVAs) calculated using the maximum timevarying elastance (Emax) have a relation with myocardial oxygen consumption (MVo2) that improves on other indexes of myocardial oxygen demand, we studied nine dogs of either sex weighing 19-39 kg, which were instrumented with a micromanometer left ventricular (LV) catheter and a Wilton-Webster coronary sinus flow catheter and had red blood cells tagged with technetium-99m for radionuclide angiography. Hemodynamics, coronary sinus flow determinations, and radionuclide angiograms were obtained under control conditions and during three to five steady-state loading conditions (mean±+SD, 5.6±0.7). Isochronal pressure-volume data points from each pressure-volume loop were subjected to linear regression analysis to calculate Emax The Emax relations, diastolic curves, and systolic portions of each pressure-volume loop were used to obtain calibrated PVAs. The Emax PVA (mm Hg* ml beat`-l 100 g-') and MVo2 (ml 02 beat`. 100 g-') values correlated in each animal (r=0.77 to 0.99). Their slopes averaged (3.48±1.68)x10-5 ml 02 'mm Hg`t ml-, and their y-axis intercepts averaged 0.07±+0.04 ml 02 beat.* 100 g`. When the MVo2 relations were compared with Emax PVA, LV systolic pressure-rate product, LV stroke work, and a modification of the LV pressure-work index, the Emax PVA, LV systolic pressure-rate product, and LV pressure-work index had similar relations with MVo2, whereas LV stroke work was a weaker index of MVo2 (p<0.05 versus Emax PVA). This occurred because the Emax PVA: MVo2 slopes andy-axis intercepts differed in each dog, which was due to differences in basal LV contractility. The Em., PVA:MVo2 slopes correlated with Emax (r=0.73, p<0.05), and the y-axis intercepts were also weakly related to Em. (r=0.48,p=0.19 
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(r=0.48,p=0.19). We conclude that the Emax PVAs calculated using data acquisition techniques that are clinically applicable have relations with MVo2 (dP/dt) were recorded for 10-20 cardiac cycles at the beginning, middle, and end of each radionuclide acquisition; coronary sinus flow measurements were recorded during the midpoint of each radionuclide acquisition on a Gould 2800S eight-channel physiological recorder at a speed of 100 mm/sec (Gould Electronics, Cleveland, Ohio). The Wilton-Webster coronary sinus flow catheter was interfaced to the physiological recorder through a Wilton-Webster CF-300 control unit, which converts resistance changes in the catheter due to alterations in temperature into calibrated voltages. Using a constant infusion of a room temperature indicator (5% dextrose infused at 38 ml/min), coronary sinus blood flow was calculated from the simultaneously recorded deflections of the calibration constant, the indicator, and the coronary sinus thermistor.25 Finally, systemic arterial and coronary sinus blood samples (0.5 ml) were obtained for analysis. All data were acquired under control conditions and during five additional steady-state hemodynamic conditions produced by either aortic or inferior vena caval constriction. At the completion of the protocol, each animal was killed, the hearts were excised, and the left ventricles were separated from the rest of the cardiac structures. The left ventricles were then weighed (mean weight, 121± 18 g; range, 85-142 g).
Hemodynamics
The micromanometer LV pressure signals recorded during each radionuclide angiogram were averaged over a minimum of 30 cardiac cycles, and the average LV pressure waveforms were hand digitized using a Calcomp 9100 inductance digitizing surface (resolution, 0.02 mm) at 200 Hz to obtain instantaneous LV pressures and dP/dt using a program developed in this laboratory.9-11,26 MVo2 was calculated using the technique of Ganz et al. 25 The systemic arterial and coronary sinus blood samples were analyzed using an ABL2 acid-base laboratory (Radiometer, Copenhagen) to obtain pH, Pco2, Po2, hemoglobin, and oxygen saturations. Using the measured hemoglobin and oxygen saturations and the oxygen-carrying capacity of hemoglobin, the systemic arterial and coronary sinus oxygen contents were calculated.27 By dividing coronary sinus blood flow obtained using the thermodilution technique by the systemic arterial-coronary sinus oxygen content difference, MVo2 was obtained.25 '27 MVo2 values are given as milliliters of 02 per beat per 100 g of LV weight.
Radionuclide Angiography
Red blood cells were tagged with 30 mCi technetium-99m using a modified in vitro labeling technique.28 A standard field of view gamma scintillation camera (Siemens Gammasonics, Inc., Solna, Sweden) equipped with an all-purpose parallel-hole collimator was used. The radionuclide images were acquired under control conditions and during each hemodynamic steady state without altering the camera position into a 64x64 byte matrix of consecutive corresponding 20-msec frames until information from 500 R-R intervals was processed. Midway through the radionuclide acquisition, a 2-ml blood sample was obtained, and the time was recorded. Each blood sample was counted on the collimator at the completion of the protocol for 2 minutes to obtain counts per 2 minutes per 2 ml. The distance from the gamma camera to the center of the left ventricle was obtained directly at the completion of the protocol.
Radionuclide frame-by-frame LV volumes were calculated from hand-drawn region-of-interest count data.10'11'2930 Briefly, the LV images were background subtracted and smoothed. Then, a hand-drawn LV region-of-interest was outlined by the operator for each frame throughout the cardiac cycle. The frame-by- [12] [13] [14] [15] 35 This index represents a potentially powerful tool for understanding the relation between MVo2 and total mechanical energy expended by the left ventricle. It can also measure the efficiency of converting total mechanical energy to external work in the normal human heart and then investigate the effects of pathophysiological conditions and pharmacological agents on these relations. Before the clinical application of this concept, however, it must be determined whether the PVA: MVo2 relation can be generated using clinically applicable methodologies and whether this index has a relation with MVo2. It is also important to determine whether this approach improves on other previously evaluated indexes of myocardial oxygen demand. We also used i8-adrenergic blockade to alleviate the effects of variations in autonomic tone on heart rate24 and, thus, on LV contractility in each animal. Because the variability in heart rate was minimal in our animals, there was probably little effect of heart rate on contractility, the calculation of the elastance slopes, or the Emax PVA:MVo2 slopes and y-axis intercepts. In patients in whom pathophysiological conditions have severely affected LV size and performance, f3-adrenergic blockade may not be indicated for this purpose. In the past, we have used right atrial pacing to maintain heart rate constant to avoid the effects of changes in heart rate on the elastance calculation. The MVo2 calculation is also subject to error. The position of the thermodilution catheter in the coronary sinus must be guaranteed to obtain reproducible MVo2 values. In our animals, the coronary sinus thermodilution catheter was placed through the right atrial appendage and firmly sutured into place so that variation in its position was minimized. It also requires 3-5 minutes for coronary sinus blood flow and oxygen extraction to come to equilibrium with myocardial oxygen demand after a change to a new steady-state hemodynamic condition,21,22 which was performed in this investigation. This will be particularly important in humans, in whom the coronary sinus flow and oxygen saturation determinations should probably be repeated, at least in duplicate, at each level of load to document the stability of coronary sinus blood flow and oxygen extraction. Consequently, rapid transient alterations in LV loading conditions may not be an appropriate approach to generate Em,x PVA:MVo2 relations. Finally, the LV thebesian vein flow would have been missed as well as minor tributary drainage of the posterior and anterior walls using the thermodilution approach to the measurement of coronary sinus blood flow, which would have led to a variable underestimation of the total venous drainage from and therefore the total MVo2 in each of our animals. Nevertheless, the potential variance in the MVo2 calculations performed using this methodology should have been minimized.
The data in the present investigation demonstrate that EmaX PVAs generated using clinically applicable data acquisition techniques have linear relations with determinations of MVo2 in this animal preparation. The Emax PVA had a relation with MVo2 that was similar to the LV systolic pressure-rate product and the LV pressure-work index: MVo2 relations but superior to the LV stroke work: MVo2 relations. Therefore, the Emax PVA:MVo2 relations did not substantially improve on two of the more easily obtained indexes of myocardial oxygen demand, which may be related to the lack of consideration by researchers of the mechanically loaded ejecting right ventricle and the effects of basal LV contractility on the EmaX PVA:MVo72 relation in the intact animal heart. The Emax PVA does, however, improve on external work as a predictor of MVo2 due to the incorporation of the internal work performed by the left ventricle represented by the potential energy portion of the PVA. Although the PVA does not appear to improve substantially on these indexes of myocardial oxygen demand in this intact animal preparation, it does represent an alternative approach for assessing the coupling of LV mechanical performance to energy use that may provide some insight into the effects of pathological processes or pharmacological agents on myocardial mechanics and energetics in humans.
